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Summary:
We developed a fibrin-rich thrombotic focal ce rebral ischemic model with reproducible and predictable infarct volume in rats. In male Wi star rats (n = 77), a thrombus was induced at the origin of the middle cercbral artery (MCA) by injection of thrombin via an intraluminal catheter placed in the intracranial segment of the internal carotid artery (ICA). Thrombus induction and consequent ischemic cell damage were examined by histopathological analysis and neurological deficit scoring, and by measuring changes in cerebral blood flow (CBF) using laser�Doppler flowmetery (LDF), perfusion-weighted imaging (PWI), and by diffusion weighted imaging (DWI) . Histopathology revealed that a Abrin-rich thrombus localized to the origin of the right MCA. Regional cerebral blood flow (rCBF) in the right parietal cortex was reduced by 34�580/0 of preinjection levels after injection of thrombin in rats admin istered 30 U of thrombin (n = 10). Magnetic resonance imaging (MRI) showed a reduction in CBF and a hyperin-Up to 80% of human strokes are caused by throm bosis or embolism (Mohr et al., 1978; Sloan, 1987) . Administration of recombinant tissue plasminogen activator (rt-PA) within three hours after onset of ischemic stroke improves neurological outcome in patients (NINDS, 1995) . With the expected use of tensity DWI encompassing the territory supplied by the right MCA. The infarct volume in rats administered 80 U of thrombin was 31.29 ± 12.9% of the contralateral hemisphere at 24 h (n = 13), and 34.7 ± 16.4% of the contralateral hemisphere at 168 h (n = 6). Rats adminis tered 30 U of thrombin exhibited a hemispheric infarct volume of 34.0 ± 14.5% (n = 9) at 24 h and 29.7 ± 13.9% (n = 8) at 168 h. In addition, thrombotic rats (n = 3) treated with recombinant tissue plasminogen activator (rt PA) (10 mg/kg) 2 h after thrombosis showed that CBF rapidly returned towards preischemic values as measured by PWI. This model of thrombotic ischemia is relevant to thromboembolic stroke in humans and may be useful in documenting the safety and efficacy of thrombolytic inter vention as well as for investigating therapies complemen tary to antithrombotic therapy. Key Words: Thrombus Focal cerebral ischemia-Rats-MRI.
antithrombotic agents for treatment of stroke, animal models of thrombotic cerebral ischemia will be re quired to assess the safety and efficacy of anti throm botic therapies and to evaluate combination thera pies. The beneficial effects of thrombolytic agents on increasing cerebral blood flow (CBF ), reducing infarct volume, and improving neurological outcome have been demonstrated using cerebrovascular thromboembolic models induced by autologous or heterologous blood clot embolization in rabbits and rats (Zivin et aI., 1985; Papadopoulos et aI., 1987; Overgaard et aI., 1993; Hamilton et aI., 1994) . How ever, a limitation of these models is the lack of repro ducibility and uniformity in the size and location of the infarcts, since placement and ultimate lodgement of the mUltiple emboli are not controlled (Hill et aI., 1955; Penar and Greer, 1987; Phillips et aI., 1988; Overgaard et aI., 1992) . Photochemically-induced emboli are platelet-rich and lack fibrin (Watson et aI., 1985) and, therefore, are not accessible to throm bolysis with rt-P A. Commonly-used models generate multiple and scattered emboli, and there is a need for a model to mimic the large cerebral artery throm bosis of human stroke. We report the development of a rat model of thrombotic focal cerebral ischemia, in which the middle cerebral artery (MeA) is selec tively occluded by thrombosis. The formation of a thrombus at the origin of the MeA and the reproduc ibility of the resulting volume of infarction were con firmed by histopathology. Thrombolysis of the oc cluded MeA in this model was also demonstrated by means of magnetic resonance imaging (MRI) after intravenous administration of rt-P A.
MATERIAL AND METHODS

Animal model
Male Wistar rats, weighing 300-450 g, (n = 77) were used in the experiments. Animals were anesthetized with 3.5% halothane, and anesthesia was maintained with 1.0% halothane in 70% N20 and 30% O2 (vol/vol) using a face mask. Rectal temperature was maintained at 37 ± O.soC throughout the surgical procedure using a feedback regulated water heating system. The right femoral artery and vein were cannulated with a PE-50 catheter for continu ous monitoring of blood pressure and measurement of blood gases (pH, P02, Pe02), and for drug administration, respectively. Under the operating microscope (Carl Zeiss, Inc., Thorpwood, NY, U.S.A.), the right and left common carotid arteries (CCA), the right external carotid artery (ECA), and the internal carotid artery (ICA) were isolated via a midline incision. A 5-0 silk suture was tied loosely at the origin of the ECA and ligated at the distal end of the ECA. The right CCA and ICA were temporarily clamped using a curved microvascular clip (Codman & Shurtleff, Inc., Randolf, MA, U.S.A.). A modified PE-50 catheter (0.3 mm O.D.), filled with bovine a-thrombin (10 NIH U/ILI) (Sigma Chemical Co., St. Louis, MO, U.S.A.), was attached to a 100-1L1 Hamilton syringe and introduced into the ECA lumen through a small puncture. The suture around the origin of the ECA was tightened around the intraluminal catheter to prevent bleeding and the microvas cular clip was removed. A 15-mm length of catheter was gently advanced from the ECA into the lumen of the ICA. At this point, the intraluminal catheter was 2-3 mm from the origin of the MCA. Then, lO1L1 of arterial blood were withdrawn into the catheter and retained for 10 min to form a clot. At 10 min after withdrawal of blood, the right and left CCA were temporarily clipped to reduce CBF and the clot in the catheter was injected into the ICA along with 30 or 80 U of a-thrombin (Fig. 1) . The clip on the left CCA was removed 5 min after injection and the cathe ter was withdrawn from the right ECA 10 min after injec tion. The right ECA was ligated. The clip on the right CCA was released 15 min after injection. The duration of the entire surgical procedure was -45 min. Heparin was not administered to any animal.
Neurologic deficits
Neurologic examinations were performed at 2, 24, and 168 h after injection of thrombin. The neurologic findings were scored on a five-point scale: no neurologic deficit, 0;
J Cereb Blood Flow Metab, Vol. 17, No. 2, 1997 FIG. 1. Schematic drawing of the catheter placed into the external carotid artery (ECA) and the internal carotid artery (ICA) of the rat, with its tip at 2 mm proximal to the origin of the middle cerebral artery (MCA). Thrombin is injected into the catheter. The right and left common carotid arteries (CCAs) are temporarily clipped during injection of thrombin.
right Horner's syndrome, 1; failure to extend left forepaw fully, 2; turning to left, 3; and circling to left, 4.
Blood analysis
Arterial blood gas (pH, Peo2, and Po2) was measured before and 15 min, 4 h, and 24 h after injection of 30 U of thrombin.
In order to assess the effect of thrombin on the blood clotting system, plasma levels of fibrinogen and crosslinked D-dimer were measured in rats without injection of throm bin (n = 5), with injection of 80 U of thrombin (n = 4), and with injection of 30 U of thrombin (n = 6). Blood from the femoral vein (2.7 ml) was collected in a tube containing 3.2% sodium citrate anticoagulant at 3 h after injection of thrombin. Blood samples were cetrifuged at 1,000 g at 10°C for 15 min. The supernatant fractions were stored at -70°C. The plasma level of fibrinogen was mea sured on a fibrometer using a fibrinogen assay kit (Pacific Hemostasis, Hunterville, NC, U.S.A.) (Clauss, 1957) and the plasma level of D-dimer was measured using a D-dimer assay kit (Pacific Hemostasis).
Monitoring of regional CBF (rCBF) by laser-Doppler flowmetery (LDF)
Relative rCBF, f, was measured using LDF. LDF was performed with a PeriFlux PF4 flowmeter (Perimed AB, Jarfalla, Sweden) with relative flow values expressed as perfusion units. The rat was mounted on the stereotactic frame. A 1.5-mm diameter burr hole was placed 1.0 mm posterior and 5.5 mm lateral to the bregma in each hemi sphere (Paxinos and Watson, 1986) . The dura was left intact and mineral oil was placed onto the burr hole. Using a micromanipulator, two probes were positioned 0.5 mm above the dural surface, with care taken to avoid any large vessels. rCBF of two hemispheres was simultaneously mea sured prior to injection of thrombin (to calculate baseline flow) and 30 min to 2 h after injection of thrombin. LDF probes were repositioned as accurately as possible so that after injection of thrombin, relative flow could be mea sured. We found <10% changes in rCBF (p > 0.05) when probes were repositioned several times on rats without thrombus induction. rCBF was recorded every 5 min and was expressed as a percentage of preischemic baseline values.
MRI measurements
Diffusion-weighted imaging (DWI) and perfusion weighted imaging (PWI) were performed with or without rt-PA treatment. MRI measurements were performed us ing a 7 T, 20-cm bore superconducting magnet (Magnex Scientific, Abingdon, U.K.) interfaced to a console (SMIS, Surrey, England). A 12-cm bore gradient coil set, capable of producing magnetic field gradients up to 20 gauss/cm and a birdcage coil with 5 cm interdiameter were used. Images were produced using a 3.2-cm field of view (FOV), 2-mm slice thickness and 128 X 64 image matrix. Stereo taxic ear bars wefe used to minimize movement during the imaging procedure. While in the magnet, animals were anesthetized using a face mask with a 70% of N20 and 30% of O2 (vol/vol) gas mixture, and halothane (0.75-1 %). Rectal temperature was maintained at 37°C using a feedback-controlled water bath. A modified FLASH (Frahm et aI., 1986) imaging sequence was employed for reproducible positioning of the animal in the magnet at each DWI session.
DWI was performed prior to injection of thrombin, con tinuously for 5 h, and at 24, 48, and 168 h after administra tion of thrombin, and with or without rt-PA treatment.
Perfusion measurements were performed using a tech nique described by Williams et al. (1992) . This method for measuring relative CBF is based on the selective inversion of blood water protons at the level of the carotid arteries prior to [IH] MRI measurement in the brain. Perfusion images were obtained prior to injection of thrombin and at various times between 1-5 h and at I, 2, and 7 days after administration of thrombin (and rt-PA). Perfusion measurement MRI parameters were: repetition time (TR) = 2 s, echo time (TE) = 30 ms, 64 x 64 image matrix, 3-mm slice thickness, and a 3.2-cm field of view. The duration of the inversion pulse was 2 s at a power level of 0.5 W. Relative CBF, f, was calculated using the equation (Williams et aI., 1992)
where M c ont and M i n v are the control and inversion image intensities, respectively; A is the blood-brain partition coef ficient; and Tl app is the apparent T l relaxation time constant of brain. Values of 0.9 g mI l for A and 1.7 s for T1app (Williams et aI., 1992) were used for CBF calculation. After the final MRI measurement, the brain was removed, and 6-p., thick coronal sections were obtained and stained with hematoxylin and eosin (H&E) for evaluation of ischemic cell damage.
Histopathology
Light microscopy. Animals were anesthetized with an intramuscular injection of ketamine (44 mg/kg/body wt/ body wt) and xylazine (13 mg/kg body weight). Rats were transcardially perfused with heparinized saline and 10% buffered formalin, and brains were removed. Using a rat brain matrix, each brain was cut into 2-mm thick coronal blocks, for a total of seven blocks per animal. The brain tissue was processed, embedded, and 6-p.,m thick paraffin coronal sections from each block were cut and stained with H&E for histopathological evaluation.
Gross hemorrhage, defined as blood evident to the un aided eye on two faces of each block and on the H&E stained sections, was evaluated in each animal.
Formation of thrombi in the origin of the MCA was examined on the H&E-stained coronal sections. Phospho tungstic acid hematoxylin (PT AH) staining was performed on 6-p.,m thick coronal cerebral sections to examine fibrin deposition (Futrell et aI., 1989; Heye et aI., 1993) . Other organs (heart, lung, liver, spleen, and kidney) were also evaluated for fibrin deposition.
Electron microscopy. Rats were perfused with saline and 3% glutaraldehyde in cacodylate buffer. A 5-mm segment of the right intracranial ICA, including the origin of the MCA, was removed and fixed in 3% glutaraldehyde in cacodylate buffer for 24 h.
For scanning electron microscopy, the segment was lon gitudinally exposed. The tissue was then postfixed in 1 % buffered osmium tetroxide for 2 h, dehydrated through progressive concentrations of ethanol for 5 min each, im mersed in hexamethyldisilizane (HMDS) (Polysci, War rington, P A, U.S.A) for another 5 min, and dried in air at room temperature. The vessel was sputter-coated with gold and examined under a JSM-840 scanning electron micro scope (JEOL, Peabody, MA, U.S.A).
For transmission electron microscopy, blocks were post fixed in 1 % buffered osmium tetroxide for 2 h, dehydrated in a graded series of ethanol, and embedded in araldite. Ultrathin sections, counterstained with uranyl acetate and lead citrate, were examined using a Philips EM 201C trans mission electron microscope (Philips Electronic Instru ments, Mahwah, NJ, U.S.A.).
Confocal microscopy. Evans blue dye (1 mg/kg body wt) was injected intravenously 10 min prior to injecting thrombin (30 U). Then, 2 h after injection of thrombin, animals were perfused with buffer containing 4% paraform aldehyde. This procedure removes Evans blue dye from patent vessels, with focal retention of the dye, indicating occluded cerebral vessels and ischemic tissue not accessible to reperfusion. The brain was removed and fixed in the same buffer for 3 days. Vibratome coronal sections (100 p.,m) were analyzed with a Bio-Rad MRC 1,024 laser scanning confocal microscope mounted onto a Zeiss micro scope (Bio-Rad, Cambridge, MA, U.S.A.). The Evans blue dye produced a bright red color during excitation with the following second filter combinations: a 545-nm primary filter, a 580-nm dichroic interference mirror, and a 590nm secondary filter. A 10 X objective was used for data acquisition. Areas of interest were scanned in 512 X 512 pixel format in the x/y direction using a 4x frame scan average. Twenty thin optical sections were scanned through a specimen along the z-axis with a 5-lLm step size.
Measurement of infarct volume
Volume of cerebral tissue infarction was measured using a Global Lab Image analysis program (Data Translation. Marlboro, MA, U.S.A.). Each H&E-stained coronal sec tion was evaluated at 2.5 X magnification. The area of infarction and the area of both hemispheres (mm 2 ) were calculated on H&E-stained sections by tracing these areas on the computer screen; volumes (mm') were determined by integrating the appropriate area with the section interval thickness. To reduce errors associated with processing of tissue for histological analysis, the infarct volume was cor rected using the method of Swanson et a!. (1990) . The area of infarction in each section was expressed as the percentage of the infarct to the area of the contralateral hemisphere, and the infarct volume was also expressed as the percentage of infarct to the contralateral hemisphere (Jiang N et a!., 1994) .
Triphenyltetrazolium chloride (TTC) staining was also performed to demonstrate infarction 24 h after thrombin injection. Brain sections from selected animals were incu bated in isotonic phosphate-buffered saline (pH 7.4) con taining 2% TTC (Sigma) at room temperature for 30 min and then stored in 10% neutral buffered formalin. Brain sections were photographed 3-5 h after fixation.
rt-PA treatment
At 2 h after successful induction of thrombosis docu mented by PWI and DWI measurements, rt-PA (Genen tech, Inc., South San Francisco, CA, U.S.A.) was adminis tered at a dose of 10 mg/kg body wt as a 10% i.v. bolus and the remainder continuously infused (i.v) over a 30-min interval using a Harvard pump (Harvard Apparatus, South Natick, MA, U.S.A.).
Experimental protocols
To evaluate thrombosis formation and the subsequent induction of a focal ischemic lesion, the following experi ments were performed:
High-dose of a-thrombin (80 U). Animals were killed 24 h (n = 18) and 168 h (n = 8) after injection of thrombin and the volume of cerebral infarction was measured.
Low dose a-thrombin (30 U). Animals were killed 24 h (n = 12) after injection of thrombin and the volume of cerebral infarction was measured.
CBF measurement to correlate relative rCBF reduction measured by LDF with cerebral infarct volume. Animals (n = 10) were killed 168 h after injection of 30 U thrombin and infarct volume was measured.
Confocal microscopy to examine the retention of Evans blue dye in the occluded MCA territory. Animals (n = 2) were killed 2 h after injection of 30 U of thrombin. 1997 Electron microscopy to examine the composition of the thrombus. Animals (n = 3) were killed 2 h after injection of 30 U of thrombin.
Thrombolysis to evaluate, by means of MRI, the effect of administration of t-PA on thrombolysis (n = 3).
Control experiments. To (a) evaluate the effect of a thrombin (80 U) on ischemic cell damage when a-thrombin was injected through an extra cranial segment of the ICA (n = 4) and (b) determine the effect of the transient reduc tion of CBF on ischemic cell damage when the right and left CCA were temporarily clamped without injection of thrombin (n = 4).
Statistics
Data were analyzed using one-way analysis of variance (ANOV A) followed by a Bonferroni t-test correction, paired {-test, and linear regression analysis. Values are pre sented as means ± SD, except for the neurological deficit scores, which are reported as medians and interquartile ranges, the 25-75th percentiles. Statistical significance was set at p < 0.05.
RESULTS
Physiological parameters
Arterial blood gas values were within normal phys iological ranges (Table 1) . The mean arterial blood pressure (MABP) was within a normal physiological range prior to injection of thrombin (102 ± 6.9 mm Hg) and 2 h after injection of 30 U of thrombin (103 :::': :: 6.0 mm Hg).
Plasma levels of fibrinogen and D-dimer
The plasma level of fibrinogen was 222 :::': :: 11.7 mg/ dl in the control group (animals were not subjected to surgical procedures) (n = 5), 68 :::': :: 20.2 mg/dl in the 80 U thrombin group (n = 4) and 188:::': :: 15.1 mg/ dl in the 30 U thrombin group (n = 6), respectively. There was a significant (p < 0.05) difference in plasma fibrinogen levels between the control and the thrombin groups. The plasma level of D-dimer was <500 ng/ml in all groups.
Neurological deficits
Animals (n = 15) killed at 24 h in the group admin istered 80 U of thrombin exhibited a median neuro- logical deficit score of 3 with an interquartile range of (2,4) at 2 h and 2 (2,2) at 24 h; animals in 30 U group (n = 10) exhibited scores 3 (2,3) at 2 h and 2 (1,2) at 24 h; rats killed at 168 h in 80 U group (n = 7) had scores of 3 (2,4) at 2 h and 2 (1,2) at 168 h.
Histopathology
Administration of thrombin resulted in the forma tion of a thrombus at the origin of the MCA. Scanning and transmission electron microscopy of the throm bosed intracranial ICA segment revealed the throm bus to be composed of fibrin, platelets, leukocytes, and erythrocytes ( Fig. 2A,B) . Fibrin deposition in the thrombus was confirmed in the ipsilateral hemi sphere by PTAH staining (Fig. 3) . Fibrin deposition evaluated by PT AH staining was not detected in the contralateral hemisphere or in the heart, lung, kid ney, spleen, and liver of rats receiving 30 U of throm bin. However, fibrin deposition was found in the lung and kidney, but not in the contralateral hemisphere in rats given 80 U of thrombin.
Confocal microscopy revealed that fluorescent ma terials (Evans blue stain and erythrocytes) were pres ent in the lumen of the ipsilateral cerebral microvas culature in the MCA territory (Fig. 4) , but not in the contralateral hemisphere. Brightly diffuse fluores cence appeared and was primarily localized to the preoptic area and striatum.
A thrombus was found in four of four (100%), five of six (83%), six of nine (67%), and 0 of 18 (0%) rats in the origin of the right MCA at 2, 4, 24, and 168 h after injection of thrombin, respectively. Gross hem orrhage in the ipsilateral lesion was detected in five of 12 (41 %) and two of six 33% rats receiving 80 U (A) of thrombin at 24 and 168 h, respectively, and two of nine (22%) and one of eight (13%) rats receiving 30 U of thrombin at 24 and 168 h, respectively.
rCBF and infarct volume
As measured by LDF, injection of 30 U thrombin resulted in a significant reduction in rCBF in the right parietal cortex by 58, 44, and 34% of preinjection levels at 60, 90, and 120 min after injection of throm bin, respectively; reduction in rCBF in the contralat eral parietal cortex was 2, 0, and 6% of preinjection levels at 60, 90, and 120 min, respectively (Fig. 5) . Linear regression analysis revealed a statistically sig nificant (p < 0.05) correlation (r = 0.76) between rCBF reduction 75 min after administration of throm bin and cerebral infarct volume.
Cerebral infarction induced by thrombin adminis tration was demonstrated by TTC ( Fig. 6) . Table 2 summarizes the absolute values of the contralateral and the ipsilateral hemispheric volumes, indirect in farct volumes, and percent infarct volume to the con tralateral hemisphere as measured on H&E-stained coronal brain sections. In contrast, ischemic cell dam age was not detected in animals infused with 80 U of thrombin through the extracranial segment of the ICA or in rats with the right and left CCAs clamped for 5 min. Three rats administered 80 U of thrombin and three rats administered 30 U of thrombin did not exhibit infarction. Rats without infarction exhibited a neurological deficit score of 0-1 at 2 h and 0 at 24 h after injection of thrombin. All other rats with in farction exhibited higher (2-4) neurological deficit scores at 2 h. Thus, a 100% success rate of infarction is achieved when neurological deficit scoring is used as an adjunctive measure. Two rats that were admin istered 80 U of thrombin exhibited infarction in the area supplied by the right anterior cerebral artery (ACA). These rats were excluded from the infarct volume calculation of the 24-h group. Two rats ad ministered 80 U of thrombin and one rat adminis tered 3G U of thrombin died after 24 h of injection of thrombin; autopsy revealed subarachnoid hemor rhage in one and massive ipsilateral hemispheric edema in two. 
MRI
Serial MRI perfusion measurements revealed a re duction in CBF encompassing the territory supplied by the right MCA ( Fig. 7 A) . CBF values in the ipsilat eral hemisphere after injection of thrombin declined from preinjection CBF values and remained low 3 h after injection. However, CBF in the right cortex increased towards preinjection values at 24, 48, and 168 h after injection of thrombin. CBF values in the subcortex remained low 168 h after injection of thrombin. The contralateral hemisphere exhibited a small reduction in CBF after injection of thrombin.
Thrombolysis resulting from administration of rt P A was evident by measuring CBF with perfusion MRI (Fig. 7B) . During infusion of rt-PA, CBF re turned rapidly towards preischemic values. CBF val ues approached preischemic values in the cortex 3 h after infusion of rt-P A. Hyperemia was detected at 48 h after infusion of rt-P A. CBF was reduced in the ipsilateral hemisphere at 166 h after administration of rt -P A when compared with the preinjection CBF value. Figure 8 presents DWI from rats that showed a reduction of CBF (Fig. 7 A) and thrombolysis ensuing from administration of rt-PA (Fig. 7B) obtained at 80 min, and 2, 3, 24, 48, and 168 h after initiation of thrombin injection. In the non-rt-PA-treated rat, hyperintensity was apparent by DWI in the ipsilateral MCA region at 80 min after injection of thrombin; image contrast incorporating Tz-weighting tended to increase as time progressed and persisted up to 168 h after injection of thrombin. In the rt-PA-treated rat, hyperintensity in the ipsilateral MCA territory was apparent within 2 h after injection of thrombin. Image contrast increased 1 h after administration of rt-P A. However, the area of hyperintensity appeared smaller at 48 h after administration of thrombin than at 100 min after administration of rt-P A. Figure 8C and D show the corresponding histological sections from the DWI and CBF images as noted in Figs. 7  and SA,B .
DISCUSSION
This study presents a new model of thrombotic focal cerebral ischemia in the rat, in which a thrombus is induced at the origin of the MCA by intraluminal injection of thrombin. Thrombus induction and con sequent ischemic cell damage were confirmed by his topathological analysis, neurological examination, and measuring changes in CBF (LDF, MRI, and DWI). Thrombin-injected animals in this model treated with rt -P A exhibited a rapid improvement of CBF. Therefore, this model enables quantitative study of the safety and efficacy of anti thrombotic therapies in thrombotic focal cerebral ischemia.
This rat model of thrombotic focal cerebral isch emia has advantages over other thrombotic models: (a) a large vessel thrombosis similar to thromboem bolic stroke in humans is produced, and the thrombus contains fibrin and is amenable to thrombolysis with rt -P A; (b) the model provides a reproducible and predictable infarct volume within the territory sup plied by the MCA; and (c) the development of throm bosis and thrombolysis can be assessed noninvasively by measuring changes in DWI and PWI.
Light and electron microscopic examination con firmed that the thrombus is composed of fibrin, plate lets, leukocytes, and erythrocytes. PT AH staining Values are mean::+: SD. 30 U and 80 U st and fo r rats ad minis tered 30 U of thrombin and 80 U of thrombin, respectively.
(B)
FIG. 7. Perfusion-weighted images (PWls) of coronal sections from a control rat brain (A) and a rat treated with rt-PA brain (B) obtained prior to, and 80 min-7 days after injection of thrombin (30 U). A rapid decline in signal intensity, which is proportional to CBF, was observed in the MCA territory (A, B) . Signal intensity remained low at 3.5 h after injection of thrombin (A). A return of signal intensity was observed in the cortex during 24-168 h after injection of thrombin (A). A rapid return of signal intensity was demonstrated after treatment with rt-PA, 2 h after injection of thrombin (B). Units are arbitrary.
demonstrated a high fibrin content of the thrombus. Specimens of carotid artery plaques obtained from humans reveal a similar composition to the rat thrombin-induced thrombus (Fisher et aI., 1993) . Re tention of Evans blue dye in the microvasculature and parenchyma in the ipsilateral preoptic area, striatum, and cortex 2 h after injection of thrombin is consistent with impairment of the blood-brain barrier (BBB) found in other models of MeA occlusion (Del Zoppo et aI., 1986) . Ischemic cell damage was not detected by light microscopy for animals subjected to 5-min bilateral ligation of the carotid arteries; this is consis-tent with the finding that 5-h bilateral carotid artery ligation does not result in cerebral ischemic lesions (Ogata et aI., 1976) . Taken together, these data dem onstrate that a fibrin-rich thrombotic focal cerebral ischemic model is produced by precisely delivering a small volume (3-8 p,l) of thrombin into the segment of the intracranial ICA 2-3 mm proximal to the origin of the MCA. A significant reduction of CBF in the ipsilateral MCA territory was confirmed by both LDF and MRI immediately after injection of thrombin. A significant reduction of CBF persisted at least 2 h after injection of thrombin. There was a consistent correlation be tween the reduction of rCBF and infarct volume, with a correlation coefficient of 0.76. Reduction in rCBF after induction of a thrombus is less than that re ported in the suture model of MCA occlusion (Yang and Betz, 1994) . Although the LDF probe was placed 5.5 mm from the midline of the ipsilateral hemi sphere, this region may not be within the ischemic core area. Consequently, the percentage reduction in rCBF may represent the perifocal area. CBF was slightly reduced in the contralateral hemisphere in the present model. Light microscopy did not reveal ischemic changes in the contralateral hemisphere.
Hypoperfusion in the contralateral hemisphere may possibly be attributed to diffusion of thrombin. How ever, CBF reduction in the contralateral MCA terri tory was also observed in the suture model of MCA occlusion (Nagasawa and Kogure, 1989; Laing et aI., 1993) . Liang et a1. (1993) reported that CBF in the contralateral MCA territory declined by 12% (at 1 h) and 11 % (at 2 h) from pre occlusion values mea sured by the hydrogen clearance method (Laing et aI., 1993) . Therefore, hypoperfusion in the contralateral hemisphere may represent interhemispheric diaschi sis during ischemia (Slater et aI., 1977) .
Infarct volume in the present model is consistent with that obtained in the suture model of MCA occlu sion in rats (Chopp et aI., 1994; Zhang et aI., 1995) . Since a thrombus blocks an intracranial segment of ICA at the origin of the MCA, a relatively uniform predictable infarct volume can be produced. This is an important endpoint if therapeutic interventions, such as t-PA administration, are to be investigated. Infarct volumes are variable in other thromboem bolic models, in which introduction of emboli via the extracranial segment of the ICA results in multifocal cerebral ischemia, with no control over the ultimate location of the emboli (Penar and Greer, 1987; Phil lips et aI., 1988; Overgaard et aI., 1992) . In addition, emboli induced by activation of a photosensitive dye do not contain fibrin and, thus, are not amenable to thrombolysis by administration of t-PA (Watson et aI., 1985) .
Evolution of the thrombotic lesion and thromboly sis in this model can be monitored by measuring DW and PW-MRI. The hyperintensity observed on DWI after thrombin injection is consistent with data ob tained from the suture model of MCA occlusion (Jiang Q et aI., 1994) . Treatment with rt-PA at 2 h after thrombus formation caused an increase in pa renchymal perfusion, as measured by MRI.
Previous studies of rt-PA treatment of thrombo embolic ischemia in the rat have shown effective thrombolysis of a heterologous blood clot, but not of an autologous blood clot (Papadopoulous et aI., 1987; Penar and Greer, 1987) . Using a human blood clot, Papadopoulos et al. (1987) showed that regional CBF increased significantly when rt-PA (1.5 mg/kg) was infused at 2 h after a thromboembolic occlusion of the rat MCA (Papadopoulos et aI., 1987) . How ever, Penar et al. failed to find an effect on patency of the occluded vessels when rt-PA (10 p,g/kg/min for 30 min) was administered immediately follow ing injection of autologous blood clots in a rat ce rebral thromboembolic model (Penar and Greer, 1987) . The fibrinolytic effect of rt-PA is species dependent. In vitro data indicate that the specific fibrinolytic effect of human rt-PA is at least ten times less in the rat than in the human (Korninger and Collen, 1981) . The therapeutic concentration of rt PA for effective thrombolysis is 1-2mg/kg in humans (NINDS, 1995) . We, therefore, employed a dose of 10 mg/kg of rt-P A. The affinity of t-PA for circulating plasminogen is low relative to the affinity of t-PA for fibrin-bound plasminogen (Sloan, 1987) . In our model, the thrombotic material is fibrin-rich and is, therefore, suitable for investigating the effects of fi brinolytic agents, e.g., rt-PA, on thrombolysis. Over gaard et al. (1993) demonstrated a significant reduc tion of infarct volume when rt-PA (20 mg/kg) was infused 2 h after fibrin-rich clots were injected via the extracranial ICA (Overgaard et aI., 1993) . Since t -PA is a serine protease, it plays a role not only in fibrinolysis but also in cell migration, epithelial differentiation, tumor invasion, and a variety of other physiological processes. Therefore, a high dose of rt -P A may affect tissue in ways other than thrombol ysis. However, we have not observed any effect on in farct volume or physiological response after admin istration of same dose of rt-PA to rats subjected to transient MCA occlusion by an intraluminal suture (n = 6) (unpublished observation). The major com plication in the use of rt -PA in thrombotic stroke is intracerebral hemorrhage (Slivka and Pulsinelli, 1987; Zivin et aI., 1988) . With the small number (n = 3) of animals treated with rt-PA in this study, our purpose in the present study was not to evaluate the effect of t-PA either on hemorrhagic transforma-
tion of ischemic cerebral infarct or on ischemic cell damage, but, rather, to demonstrate the utility of this model for investigating thrombolytic therapy. Gross hemorrhagic infarct was observed in 13-41 % of animals. This is in agreement with data obtained from patients with ischemic stroke. Autopsy studies have revealed that 18-42% of infarcts are grossly hemorrhagic in patients with ischemic stroke (Lodder et aI., 1986; Lyden et aI., 1987) . Gross hemorrhage occurs most often in embolic stroke in humans. Fisher and Adams (1987) reported that in two-thirds of 57 embolic stroke cases, the infarct was partly hemor rhagic (Fisher and Adams, 1987) . The incidence of gross hemorrhage increases in large cerebral infarct, since large infarcts place more cerebral vessels at risk than do smaller ones (Lodder, 1984; Hornig et aI., 1986) . Secondary hemorrhage worsens the clinical symptoms of patients with hemorrhagic infarction through formation of hematomas (Hornig et aI., 1986) . However, the pathogenesis of hemorrhagic in farction is poorly defined. In the present study, we did not quantify the area of hemorrhage or correlate hemorrhage with infarct volume. Nonetheless, there were no grossly apparent differences in infarct size between hemorrhagic and nonhemorrhagic in farctions.
In our study, evaluation of neurological deficit scores revealed values similar to those reported by Zea Longa et a1. (1989) in the suture model of MCA occlusion (Zea Longa et aI., 1989) . They observed that neurological deficit mean scores were 1.6 (cir cling to the left) at 2 h and decreased to 0.7 (failure to extend left forepaw fully) at 72 h after the onset permanent MCA occlusion. In comparison, we found neurological deficit median scores of 3 (circling to the left) at 2 h and 2 (failure to extend left forepaw fully) at 24 and 168 h after the onset of thrombus, re spectively.
Thrombin cleaves specific arginine-glycine bonds in fibrinogen, releasing fibrinopeptides A and B (FPA and FPB from the N-terminals of the 0' and f3 chains and yielding fibrin monomer (Nossel, 1981) . Thrombin has been used to induce experimental in travascular thrombosis (Collen et aI., 1983; Golzarian et aI., 1994) . Since thrombin is injected into an end of a ligated vessel, it only reacts with the blood in the ligated vessel to form a thrombus. A potential drawback of the present method of inducing throm bosis by injecting thrombin is the difficulty in localiz-ing thrombin, since the distal end of the ICA (intra cranial segment of the ICA) is open. We overcame this difficulty by withdrawing a small volume blood (10 ,ul) to form a clot in the catheter and injecting this clot into the intracranial segment of the ICA to serve as a plug. Thrombin is injected along with the clot to form a local thrombus. Thrombin has a half life of seconds when infused in vivo, due to rapid reversible binding to the vascular endothelium (Krishnamurti et aI., 1993) . Our technique of initial intraluminal clot formation minimizes the effects of thrombin on the circulating blood.
The plasma level of fibrinogen was within a normal range in the control animals (Baker et aI., 1979) . Rats administered 80 U of thrombin demonstrate a decrease in plasma level of fibrinogen associated with renal and lung fibrin deposition. These data indicate that 80 U of thrombin not only induces a thrombus in brain but also produces thrombi in other organs. However, rats administered 30 U of thrombin exhibit a mild decrease in circulating fibrinogen, without evi dence of fibrin deposition in other organs except the ipsilateral hemisphere. The lack of fibrin deposition in other organs suggests that 30 U of thrombin in duces a thrombus without producing systemic thrombi. In the absence of other coagulation defects, when the fibrinogen level is > 100 mg/dl, the blood coagulation system is not altered (Sloan, 1987) . Thus injection of 30 U of thrombin in our model produced a thrombus localized to the MCA without emboli distributed to the contralateral hemisphere or other organs. In addition, the 30 U dose of thrombin should not affect systemic blood coagulation. D-dimer is a byproduct of the digestion of cross linked fibrin by plasmin (Whitaker et aI., 1984; Con ard and Samama, 1987) . It is thought to be a marker of fibrinolysis as reflected by plasmin activity on fibrin (Ono et aI., 1991) . The absence of change in plasma D-dimer levels found in our study may be explained by the possibility that the antibody against the human D-dimer used in our study may not cross react with rat D-dimer; alternatively, endogenous fibrinolysis may not be activated after 3 h of administration of thrombin.
Studies in stroke patients suggest that infarcted brain might activate endogenous thrombin activity. A significant increase in plasma thrombin activity has been demonstrated during the acute phase of ischemic stroke by measuring plasma levels of FP A, FIG. 8. OWls of coronal sections from the animal brains shown in Fig. 7 with (8) or without (A) treatment with rt-PA showing the evolution of OW hyperintensity, obtained prior to and 80 min-7 days after injection of thrombin (30 U). H&E-stained coronal section (e) from the rat shown in (A) and H&E-stained coronal section (0) from the rat shown in (8), obtained 1 week after injection of thrombin. Recombinant t-PA was administered at 2 h after injection of thrombin. a marker reflecting thrombin activIty (Lane et ai., 1983; Feinberg et ai., 1989; Tohgi et ai., 1990) . How ever, thrombin is a multifunctional protease (Cough lin, 1994) that mediates not only hemostasis and thrombosis but also inflammatory and proliferative responses (Cohen et ai., 1991) . One of the actions of thrombin, among the many proinftammatory actions, is to rapidly upregulate P-selectin (Sugama et ai., 1992), a granular component of the Weibel-Palade body in endothelial cells and azurophilic granules of platelets (Bonfanti et ai., 1989) , which promotes leukocyte adhesion to endothelial cells. Leukocytes may contribute to ischemic cell damage. Therefore, one of the potential issues to be addressed is whether thrombin exerts stimulatory actions in the upregu lation of P-selectin and, consequently, causes more leukocyte accumulation in this model than in other models of focal cerebral ischemia induced by non thrombin techniques. We are currently engaged in studies that address this question.
The rCBF was higher at 2 than at 1 h after thrombo sis. This suggests initiation of spontaneous thrombol ysis. The frequency of the thrombus in the origin of the MCA is 83% at 4 h after injection of thrombin. Autolysis may also explain why some animals did not exhibit infarction. Spontaneous recanalization has also been � observed after injection of autologous blood clots in rats (Overgaard et aI., 1994) . Emboli mainly blocked the ICA immediately after injection of clots. However, emboli only blocked MCA branches 3 h after injection of clots, as measured by an angiography (Overgaard et aI., 1994) .
In summary, we have demonstrated that a rat model of thrombotic focal cerebral ischemia induced by thrombin results in a reproducible and predictable infarct volume and permits continuous observation of the process of thrombolysis after administration of rt -P A. This model of thrombotic ischemia is rele vant to thromboembolic stroke in humans and may be useful in documenting the safety and efficacy of thrombolytic intervention as well as investigating therapies complementary to antithrombotic therapy.
